Dashboard
Manage Tickers

ALGS Aligos Therapeutics, Inc.

Nasdaq www.aligos.com


$ 9.92 $ -0.52 (-4.95 %)    

Friday, 17-Oct-2025 15:59:52 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 604.92 $ 3.94 (0.66 %)
DIA $ 461.73 $ 2.22 (0.48 %)
SPY $ 665.28 $ 3.75 (0.57 %)
TLT $ 91.09 $ -0.14 (-0.15 %)
GLD $ 391.28 $ -7.46 (-1.88 %)
$ 9.99
$ 10.53
$ 9.50 x 40
$ 11.34 x 45
$ 9.66 - $ 10.80
$ 3.76 - $ 46.80
69,309
na
122.9M
$ 0.00
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-06-2025 06-30-2025 10-Q
2 05-06-2025 03-31-2025 10-Q
3 03-10-2025 12-31-2024 10-K
4 11-06-2024 09-30-2024 10-Q
5 08-06-2024 06-30-2024 10-Q
6 05-07-2024 03-31-2024 10-Q
7 03-12-2024 12-31-2023 10-K
8 11-02-2023 09-30-2023 10-Q
9 08-03-2023 06-30-2023 10-Q
10 05-04-2023 03-31-2023 10-Q
11 03-09-2023 12-31-2022 10-K
12 11-02-2022 09-30-2022 10-Q
13 08-04-2022 06-30-2022 10-Q
14 05-04-2022 03-31-2022 10-Q
15 03-10-2022 12-31-2021 10-K
16 11-04-2021 09-30-2021 10-Q
17 08-05-2021 06-30-2021 10-Q
18 05-10-2021 03-31-2021 10-Q
19 03-23-2021 12-31-2020 10-K
20 11-25-2020 09-30-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

aligos-therapeutics-says-usan-council-adopts-pevifoscorvir-sodium-as-generic-name-for-alg-000184-under-investigation-for-treatment-of-chronic-hepatitis-b-virus-infection
Aligos Therapeutics Says USAN Council Adop...
10/16/2025 12:35:08

Aligos Therapeutics, Inc. (NASDAQ:ALGS), a clinical stage biopharmaceutical company focused on improving patient outcomes throu...

hc-wainwright--co-reiterates-buy-on-aligos-therapeutics-maintains-50-price-target
HC Wainwright & Co. Reiterates Buy on Alig...
09/12/2025 15:27:45

HC Wainwright & Co. analyst Patrick R. Trucchio reiterates Aligos Therapeutics (NASDAQ:ALGS) with a Buy and maintains $5...

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
08/27/2025 21:06:08

hc-wainwright--co-assumes-aligos-therapeutics-at-buy-announces-price-target-of-50
HC Wainwright & Co. Assumes Aligos Therape...
08/18/2025 10:59:55

HC Wainwright & Co. analyst Patrick R. Trucchio assumes Aligos Therapeutics (NASDAQ:ALGS) with a Buy rating and announce...

aligos-therapeutics-doses-first-subject-in-phase-2-b-supreme-study-of-alg-000184-with-chronic-hbv-infection-subjects
Aligos Therapeutics Doses First Subject In...
08/13/2025 12:31:56

aligos-therapeutics-q2-eps-153-beats-236-estimate-sales-96500k-beat-43333k-estimate
Aligos Therapeutics Q2 EPS $(1.53) Beats $...
08/06/2025 20:14:44

Aligos Therapeutics (NASDAQ:ALGS) reported quarterly losses of $(1.53) per share which beat the analyst consensus estimate of $...

Core News & Articles
Earnings Scheduled For August 6, 2025
08/06/2025 08:33:21

Core News & Articles
12 Health Care Stocks Moving In Monday's I...
05/12/2025 17:07:15

aligos-therapeutics-q1-eps-211-beats-274-estimate-revenue-31100k-miss-33333k-estimate
Aligos Therapeutics Q1 EPS $(2.11) Beats $...
05/06/2025 12:02:19

Aligos Therapeutics (NASDAQ:ALGS) reported quarterly losses of $(2.11) per share which beat the analyst consensus estimate of $...

Core News & Articles
Earnings Scheduled For May 6, 2025
05/06/2025 08:32:41

aligos-therapeuticss-earnings-outlook
Aligos Therapeutics's Earnings Outlook
05/05/2025 20:03:07

aligos-therapeutics-announces-eight-abstracts-accepted-for-presentation-at-easl-congress-2025-in-amsterdam--netherlands
Aligos Therapeutics Announces Eight Abstra...
04/23/2025 20:08:27

Aligos Therapeutics, Inc. (NASDAQ:ALGS), a clinical stage biopharmaceutical company focused on improving patient outcomes throu...

hc-wainwright--co-reiterates-buy-on-aligos-therapeutics-maintains-70-price-target
HC Wainwright & Co. Reiterates Buy on Alig...
03/31/2025 11:23:13

HC Wainwright & Co. analyst Ed Arce reiterates Aligos Therapeutics (NASDAQ:ALGS) with a Buy and maintains $70 price target.

hc-wainwright--co-maintains-buy-on-aligos-therapeutics-lowers-price-target-to-70
HC Wainwright & Co. Maintains Buy on Aligo...
03/11/2025 12:55:34

HC Wainwright & Co. analyst Ed Arce maintains Aligos Therapeutics (NASDAQ:ALGS) with a Buy and lowers the price target f...

nasdaq-sp-500-hit-6-month-lows-as-recession-fears-grow-whats-driving-markets-monday
Nasdaq, S&P 500 Hit 6-Month Lows As Recess...
03/10/2025 16:59:43

Stocks extended last week's losses on Monday as concerns over the U.S. economy continue to weigh on the market. The Nasdaq ...

aligos-therapeutics-q4-eps-1308-misses-230-estimate-sales-62900k-beat-43333k-estimate
Aligos Therapeutics Q4 EPS $(13.08) Misses...
03/10/2025 12:03:56

Aligos Therapeutics (NASDAQ:ALGS) reported quarterly losses of $(13.08) per share which missed the analyst consensus estimate o...

earnings-scheduled-for-march-10-2025
Earnings Scheduled For March 10, 2025
03/10/2025 08:32:14

aligos-therapeutics-announces-105m-private-placement-financing-proceeds-expected-to-fund-the-start-of-its-alg-000184-phase-2-study
Aligos Therapeutics Announces $105M Privat...
02/12/2025 12:04:51

how-is-the-market-feeling-about-aligos-therapeutics
How Is The Market Feeling About Aligos The...
01/14/2025 13:45:23

12-health-care-stocks-moving-in-mondays-pre-market-session
12 Health Care Stocks Moving In Monday's P...
01/13/2025 12:05:38

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION